Eyeworld

EW NEWS & OPINION February 2016 25 unlikely to be used. The MIGS proce- dure can be executed quickly and easily, maximizing the number of patients that can be treated by a sin- gle doctor. Fewer complications and an expedited recovery time trans- late to decreased need for extensive postop care. Global philanthropy as well as technology development is important to Glaukos. "Part of our core mission is to give back to the glaucoma community. We care deeply about our patients and are committed to creating a legacy of US/LAC/14/0008a V ts affiliates. Lacrisert is a trademark of aleant Pharmaceuticals Inte national, Inc. or its affiliates. Bausch + Lomb is a trademark of Bausch & Lomb Incorporated or i ©2014 Bausch & Lomb Incorporated goodwill that improves the lives of glaucoma patients worldwide," said Thomas Burns, Glaukos CEO. In total, the company has approved every individual charitable request proffered to date and has donated stents to more than 2,200 individ- uals in 16 developing countries and underserved regions, including Bolivia, the Dominican Republic, El Salvador, Ethiopia, Fiji, Guatemala, Haiti, Honduras, Mongolia, Nepal, Nicaragua, Nigeria, Peru, Sierra Leon, and the United States. The company was part of a col- laborative effort to conduct research and train local surgeons in Armenia. In addition to their research efforts, 20% of the devices they implanted there were purely charitable, donat- ed to patients unconnected with the study. They also provide ongoing, pro bono clinical services to further their commitment to improving vision around the world. Glaukos has increased the reach of their charitable donations by making the iStent available to a wide variety of universities and charitable organizations including the ASCRS Foundation, the First Methodist United Church, Friends of Rudy Nicaraguan Health, Fundacion de la Tierra, Hospital de la Familia, the International Association of Lions Clubs, the International Eye Institute, Moran Eye Center, the Mission at Natuvu Creek, Missionary Ventures International, Operation Sight, St. John the Baptist Peru Eye Mission, Surgical Eye Expeditions, the University of Utah, the Virtue Foundation, and the Visionary Ophthalmology Foundation. Many of those who suffer from vision impairment have limited re- sources and may have limited access to ophthalmological care. With the iStent, Glaukos meets a need in the glaucoma community. EW Reference 1. www.icoph.org/resources/146/The-Global- Economic-Cost-of-Visual-Impairment.html Editors' note: Dr. Brown has financial interests with Glaukos. Contact information Brown: reaymary@comcast.net

• Cover